September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
August 18th 2024
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.
August 17th 2024
Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.
June 24th 2024
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
Latebreakers: Data collection laws challenged
New state laws in Maine and Vermont that would allow doctors to limit access to their prescription records have been challenged in court by data collection companies IMS Health, Wolters Kluwer Health, and Verispan.
Latebreakers: Topical thrombin of human origin approved
Evithrom is indicated to stop minor bleeding from capillaries and small veins when control of bleeding by standard surgical techniques is ineffective or impractical.
Latebreakers: DEA revokes Internet pharmacy's registration
Drug Enforcement Administration revokes the registration for United Prescription Services in an effort to crack down on Internet pharmacies.
Latebreakers: Asthma guidelines updated
New asthma guidelines released from the National Asthma Education and Prevention Program.
Latebreakers: Nausea/vomiting drug can be given more often
Aloxi's new indication approval allows the antiemetic to be given from once a week to more than once weekly.
Latebreakers: New indication granted for oncology product
Dexrazoxane approved for a new indication.
Latebreakers: NAPLEX intrigue continues
NAPLEX exams have been halted and a judge has issued a gag order in the case pitting the National Association of Boards of Pharmacy against the University of Georgia and a pharmacy faculty member.
Viewpoint: Bigfoot, Loch Ness monster, medication therapy management
Most pharmacists are still not providing medication therapy management, although it is required by law under Medicare Part D.
Supermarket pharmacies maintain their stride in 2006
This article deals with FMI's Supermarket Pharmacy 2007 trend survey results.
New Products: September 17, 2007
Review of new branded drugs, generics, OTCs, home health products, health and beauty aids, etc.
Health care a hot issue for Presidential candidates
Pharmacists could turn out to be a key factor in the 2008 presidential election. With 10 Republicans and eight Democrats in the running at last count, health care is already emerging as a top issue.
FDA's proposed rule for OTC sunscreens includes UVA ratings
FDA's proposal for new sunscreen regulations address UVA rays as well as other measures consumers may take to protect themselves from UVB rays.
Trapped in one's own skin
Psoriasis is a fairly common but relatively untreated skin condition that has shown recent advances in treatment.
Medicare Part D and consumer purchase decisions
Medicare Part D was a remarkable development, not only for establishing a prescription drug benefit but for giving consumers more responsibility for their insurance and prescription purchase decisions.
Eye on ethics: Free is a very good price
Pharmacists do not begrudge the assistance given to the patient in need, but what happens to the community pharmacist when drugs are given away?
From IVRs to PHRs, more technologies beckon pharmacies
Technologies focus on improving automation and boost efficiency at the NACDS Technology conference.
Community R.Ph.s leaving growing mark in MTM programs
New medication therapy management programs are expanding community practice opportunities.
Late-stage HTN drugs show promise
A medication in a new class of drugs has received FDA approval for hypertension and we now have several promising and innovative agents in late-stage development for treatment of the condition.
Report shows slow progress on antimicrobial misuse
Decades of campaigns against antibiotic overuse have produced only marginal reductions in use.
Clinical Twisters: Hypertension: Upping the ante
Patient appears asymptomatic for heart failure; has hypertension and diabetes, what is the maximum dose of Losartan?
New guide adds options for kidney cancer
Recent approvals have provided new options for treating kidney cancer. Updated guidelines will help utilize the new drugs.
Evidence-based guide helps detect and treat sepsis
Evidence-based guidelines and tools are available to help reduce mortality and length of stay; one major hurdle to conquering severe sepsis is having these tools readily available.
Multiple changes spawn new UA/NSTEMI guidelines
The American College of Cardiology and the American Heart Association have updated their guidelines for the drug therapy used to treat patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction.
Expert shares fears of TB and AIDS resistance
The 2006 U.S. incidence rate for tuberculosis is the lowest since the start of national records. But unless we are careful how we give medications out around the world, we could create caldrons of TB drug resistance a plane-ride awa
Letters to the editor: September 17, 2007
An extended-release form of Depakote does not have enteric coating, as an author from FDA claims. So charges a pharmacist who wrote to us.
Former pharmacist indicted for manslaughter after med error
Pharmacist is indicted for manslaughter after medication error that results in the death of a two-year old girl.
Back-to-school plans should include proper medication use
Back-to-school planning should include medication plan
OIG faults OptionCare over rebate
OIG examines OptionCare's vendor rebates
Pioglitazone study shows reduction in death risk
A pioglitazone (Actos, Takeda) study from Cleveland Clinic shows a reduction in stroke, myocardial infarction and death
CMS proposal wastes pharmacists' time, ASHP charges
ASHP calls proposal "burdensome"